301 related articles for article (PubMed ID: 16084404)
1. Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis.
Feng J; El-Assal ON; Besner GE
Semin Pediatr Surg; 2005 Aug; 14(3):167-74. PubMed ID: 16084404
[TBL] [Abstract][Full Text] [Related]
2. Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats.
Feng J; El-Assal ON; Besner GE
J Pediatr Surg; 2006 Jan; 41(1):144-9; discussion 144-9. PubMed ID: 16410124
[TBL] [Abstract][Full Text] [Related]
3. Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis.
Feng J; Besner GE
J Pediatr Surg; 2007 Jan; 42(1):214-20. PubMed ID: 17208569
[TBL] [Abstract][Full Text] [Related]
4. Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis.
Dvorak B; Khailova L; Clark JA; Hosseini DM; Arganbright KM; Reynolds CA; Halpern MD
J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):11-8. PubMed ID: 18607263
[TBL] [Abstract][Full Text] [Related]
5. Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis.
Feng J; El-Assal ON; Besner GE
J Pediatr Surg; 2006 Apr; 41(4):742-7; discussion 742-7. PubMed ID: 16567187
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model.
Dvorak B; Halpern MD; Holubec H; Williams CS; McWilliam DL; Dominguez JA; Stepankova R; Payne CM; McCuskey RS
Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G156-64. PubMed ID: 11751169
[TBL] [Abstract][Full Text] [Related]
7. Heparin-binding epidermal growth factor-like growth factor protects rat intestine from ischemia/reperfusion injury.
Pillai SB; Hinman CE; Luquette MH; Nowicki PT; Besner GE
J Surg Res; 1999 Dec; 87(2):225-31. PubMed ID: 10600353
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis.
Clark JA; Lane RH; Maclennan NK; Holubec H; Dvorakova K; Halpern MD; Williams CS; Payne CM; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G755-62. PubMed ID: 15528252
[TBL] [Abstract][Full Text] [Related]
9. Tissue distribution and plasma clearance of heparin-binding EGF-like growth factor (HB-EGF) in adult and newborn rats.
Feng J; Mehta VB; El-Assal ON; Wu D; Besner GE
Peptides; 2006 Jun; 27(6):1589-96. PubMed ID: 16364500
[TBL] [Abstract][Full Text] [Related]
10. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment.
Clark JA; Doelle SM; Halpern MD; Saunders TA; Holubec H; Dvorak K; Boitano SA; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G938-49. PubMed ID: 16798726
[TBL] [Abstract][Full Text] [Related]
11. Role of epidermal growth factor and other growth factors in the prevention of necrotizing enterocolitis.
Nair RR; Warner BB; Warner BW
Semin Perinatol; 2008 Apr; 32(2):107-13. PubMed ID: 18346534
[TBL] [Abstract][Full Text] [Related]
12. Timing, route, and dose of administration of heparin-binding epidermal growth factor-like growth factor in protection against intestinal ischemia-reperfusion injury.
Martin AE; Luquette MH; Besner GE
J Pediatr Surg; 2005 Nov; 40(11):1741-7. PubMed ID: 16291163
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor reduces hepatic sequelae in experimental necrotizing enterocolitis.
Halpern MD; Holubec H; Clark JA; Saunders TA; Williams CS; Dvorak K; Dvorak B
Biol Neonate; 2006; 89(4):227-35. PubMed ID: 16319449
[TBL] [Abstract][Full Text] [Related]
14. HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation.
El-Assal ON; Besner GE
Gastroenterology; 2005 Aug; 129(2):609-25. PubMed ID: 16083716
[TBL] [Abstract][Full Text] [Related]
15. M1 to M2 macrophage polarization in heparin-binding epidermal growth factor-like growth factor therapy for necrotizing enterocolitis.
Wei J; Besner GE
J Surg Res; 2015 Jul; 197(1):126-38. PubMed ID: 25913486
[TBL] [Abstract][Full Text] [Related]
16. Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury.
Xia G; Martin AE; Besner GE
J Pediatr Surg; 2003 Mar; 38(3):434-9. PubMed ID: 12632363
[TBL] [Abstract][Full Text] [Related]
17. Role of epidermal growth factor in the pathogenesis of neonatal necrotizing enterocolitis.
Warner BW; Warner BB
Semin Pediatr Surg; 2005 Aug; 14(3):175-80. PubMed ID: 16084405
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor and necrotizing enterocolitis.
Coursodon CF; Dvorak B
Curr Opin Pediatr; 2012 Apr; 24(2):160-4. PubMed ID: 22227788
[TBL] [Abstract][Full Text] [Related]
19. Heparin-binding EGF-like growth factor protects intestinal stem cells from injury in a rat model of necrotizing enterocolitis.
Chen CL; Yu X; James IO; Zhang HY; Yang J; Radulescu A; Zhou Y; Besner GE
Lab Invest; 2012 Mar; 92(3):331-44. PubMed ID: 22157721
[TBL] [Abstract][Full Text] [Related]
20. Intestinal mucosa remodeling by recombinant human epidermal growth factor(1-48) in neonates with severe necrotizing enterocolitis.
Sullivan PB; Lewindon PJ; Cheng C; Lenehan PF; Kuo BS; Haskins JR; Goodlad RA; Wright NA; de la Iglesia FA
J Pediatr Surg; 2007 Mar; 42(3):462-9. PubMed ID: 17336181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
